Abstract
The models available in the literature for the in silico prediction of ADME (absorption, distribution, metabolism, excretion) properties, as well as the data sets used to derive them, are reviewed. Special emphasis is given to describe the latest and most complete models, with the largest and most diverse data sets. Models for human intestinal absorption, oral bioavailability, plasma protein binding, blood-brain barrier permeation, Pglycoprotein substrates and inhibitors, and metabolism are reviewed and discussed. An attempt is made to describe the general picture emerging from each set of models when possible, as well as the issues remaining to address in the different areas for future work. These models are an example of the utility of models and computer simulations for the prediction of pharmacokinetics.
Keywords: in silico adme prediction, qsar, human intestinal absorption, bioavailability, plasma protein binding, bloodbrain barrier permeation, p-glycoprotein, metabolism
Current Computer-Aided Drug Design
Title: In Silico ADME Prediction: Data Sets and Models
Volume: 1 Issue: 4
Author(s): Gonzalo Colmenarejo
Affiliation:
Keywords: in silico adme prediction, qsar, human intestinal absorption, bioavailability, plasma protein binding, bloodbrain barrier permeation, p-glycoprotein, metabolism
Abstract: The models available in the literature for the in silico prediction of ADME (absorption, distribution, metabolism, excretion) properties, as well as the data sets used to derive them, are reviewed. Special emphasis is given to describe the latest and most complete models, with the largest and most diverse data sets. Models for human intestinal absorption, oral bioavailability, plasma protein binding, blood-brain barrier permeation, Pglycoprotein substrates and inhibitors, and metabolism are reviewed and discussed. An attempt is made to describe the general picture emerging from each set of models when possible, as well as the issues remaining to address in the different areas for future work. These models are an example of the utility of models and computer simulations for the prediction of pharmacokinetics.
Export Options
About this article
Cite this article as:
Colmenarejo Gonzalo, In Silico ADME Prediction: Data Sets and Models, Current Computer-Aided Drug Design 2005; 1 (4) . https://dx.doi.org/10.2174/157340905774330318
DOI https://dx.doi.org/10.2174/157340905774330318 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diagnosis and Management of Lynch Syndrome
Recent Patents on Regenerative Medicine New Immunosuppressants: Immunosuppression and Immunomodulation
Medicinal Chemistry Reviews - Online (Discontinued) Imaging in Inflammatory Bowel Disease Mucosal Healing in Ulcerative Colitis: Relevance for Clinical Outcomes
Current Drug Targets Growth Factor/Peptide Receptor Imaging for the Development of Targeted Therapy in Oncology
Current Pharmaceutical Design Needle in a Haystack: Targeting Specific Glucuronidases Amid the Human Microbiome
Current Enzyme Inhibition Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders
Current Pharmaceutical Design Targeted Alpha Therapy with 227Th-trastuzumab of Intraperitoneal Ovarian Cancer in Nude Mice
Current Radiopharmaceuticals The Immunomodulating Activities of Resveratrol Glucosides in Humans
Recent Patents on Food, Nutrition & Agriculture Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs
Current Pharmaceutical Design The Potential of 11C-acetate PET for Monitoring the Fatty Acid Synthesis Pathway in Tumors
Current Pharmaceutical Biotechnology Stimuli-responsive Drug Delivery Nanosystems: From Bench to Clinic
Current Nanomedicine Indian Indigenous Fruits as Radioprotective Agents: Past, Present and Future
Anti-Cancer Agents in Medicinal Chemistry Current Insights into the Role of HIF-1 in Cutaneous Wound Healing
Current Molecular Medicine Immunomodulatory Lactoferrin in the Regulation of Apoptosis Modulatory Proteins in Cancer
Protein & Peptide Letters NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Quinoline as a Privileged Scaffold in Cancer Drug Discovery
Current Medicinal Chemistry Protein Glycation: An Old Villain is Shedding Secrets
Combinatorial Chemistry & High Throughput Screening Neuropeptides as Therapeutic Approach to Autoimmune Diseases
Current Pharmaceutical Design Structure-Affinity-Relationship Study of Bicyclic σ Receptor Ligands
Central Nervous System Agents in Medicinal Chemistry ADAM Proteases: Protective Role in Alzheimers and Prion Diseases ?
Current Alzheimer Research